- Feb.28,2019 News release FIMECS Presents IRAK-M Protein Degraders for Immuno-oncology at the AACR Annual Meeting 2019 157.47 KB
- Nov.28,2018 News release FIMECS to Present at the 41th Annual meeting of the Molecular Biology Society of Japan
- Oct.25,2018 News release 代表取締役冨成祐介が日経バイオテク プロフェッショナルセミナーに登壇します
- Oct.23,2018 News release FIMECS to Present at Targeted Protein Degradation Summit 2018
- May.28,2018 News release FIMECS, Inc. Enters a New Research Collaboration with National Institute of Genetics 160.33 KB
- May.28,2018 News release FIMECS to Present at the Start-Up Stadium in 2018 BIO International Convention
- Apr.10,2018 News release FIMECS, Inc. Concludes Licensing Agreement with Takeda to Develop Novel Immuno-Oncology Therapies 159.23 KB
- Feb.12,2018 News release FIMECS, Inc. has been established